Aptadel Therapeutics awarded Eurostars grant
Aptadel Therapeutics awarded Eurostarsgrant for a first-in-class RNA-basedtargeted therapy for childhood cancer Barcelona, Spain, May, 11th 2022.Aptadel Therapeutics, – together with leading EU biotech companies, iCellate and Anapharm,– has been awarded a Eurostars grant, subsidised by CDTI, for a first in-class RNA Aptamer-based targeted therapyand companion diagnostic for childhood cancer Ewing Sarcoma (ES), to bring …